Guided filter with support wire and methods of use

Information

  • Patent Grant
  • 6652505
  • Patent Number
    6,652,505
  • Date Filed
    Friday, September 29, 2000
    24 years ago
  • Date Issued
    Tuesday, November 25, 2003
    21 years ago
Abstract
A guided filter system for temporary placement of a filter in an artery or vein is disclosed. The system includes a guidewire slideable through a wire guide included in a distal region of a support wire. The support wire has an expandable filter, which is operable between a collapsed or enlarged condition. A variety of endovascular devices, including angioplasty, atherectomy, and stent-deployment catheters, are insertable over the guidewire and/or the support wire. Methods of using the guided filter system to direct and exchange endovascular devices to a region of interest, and to entrap and remove embolic material from the vessel are also disclosed.
Description




FIELD OF THE INVENTION




The present invention relates generally to devices and methods for providing temporary placement of a filter in a blood vessel. More particularly, the invention provides a guidewire system for entrapment of embolic material in an artery or vein during an endovascular procedure. The system also provides a support wire for directing and/or exchanging other “over the wire” devices, such as angioplasty, atherectomy, or stent deployment catheters, to a region of interest within the vessel.




BACKGROUND OF THE INVENTION




Treatment of thrombotic or atherosclerotic lesions in blood vessels using an endovascular approach has recently proven to be an effective and reliable alternative to surgical intervention in selected patients. For example, directional atherectomy and percutaneous translumenal coronary angioplasty (PTCA) with or without stent deployment are useful in treating patients with coronary occlusion. Atherectomy physically removes plaque by cutting, pulverizing, or shaving in atherosclerotic arteries using a catheter-deliverable endarterectomy device. Angioplasty enlarges the lumenal diameter of a stenotic vessel by exerting mechanical force on the vascular walls. In addition to using angioplasty, stenting, and/or atherectomy on the coronary vasculature, these endovascular techniques have also proven useful in treating other vascular lesions in, for example, carotid artery stenosis, peripheral arterial occlusive disease (especially the aorta, the iliac artery, and the femoral artery), renal artery stenosis caused by atherosclerosis or fibromuscular disease, superior vena cava syndrome, and occlusive iliac vein thrombosis resistant to thrombolysis.




It is well recognized that one of the complications associated with endovascular techniques is the dislodgment of embolic materials generated during manipulation of the vessel, thereby causing occlusion of the narrower vessels downstream and ischemia or infarct of the organ which the vessel supplies. In 1995, Waksman et al. disclosed that distal embolization is common after directional atherectomy in coronary arteries and saphenous vein grafts. See Waksman et al., American Heart Journal 129(3): 430-5 (1995), incorporated herein by reference. This study found that distal embolization occurs in 28% (31 out of 111) of the patients undergoing atherectomy. In January 1999, Jordan, Jr. et al. disclosed that treatment of carotid stenosis using percutaneous angioplasty with stenting is associated with more than eight times the rate of nicroemboli seen using carotid endarterectomy. See Jordan, Jr, et al. Cardiovascular surgery 7(1): 33-8 (1999), incorporated herein by reference.




Microemboli, as detected by transcranial Doppler monitoring in this study, have been shown to be a potential cause of stroke. The embolic materials include calcium, intimal debris, atheromatous plaque, thrombi, and/or air.




There are a number of devices designed to provide blood filtering for entrapment of vascular emboli. The vast majority of these devices are designed for permanent placement in veins to prevent pulmonary embolism. A temporary venous filter device is disclosed in Bajaj, U.S. Pat. No. 5,053,008 (this and all other references cited herein are expressly incorporated by reference as if fully set forth in their entirety herein). The Bajaj device is an intracardiac catheter for temporary placement in the pulmonary trunk of a patient predisposed to pulmonary embolism due to, e.g., hip surgery, major trauma, major abdominal or pelvic surgery, or immobilization. The Bajaj device includes an umbrella made from meshwork which traps venous emboli before they reach the lungs. This device is designed for venous filtration and is not suitable for arterial use because of the hemodynamic differences between arteries and veins.




There are very few intravascular devices designed for arterial use. Arteries are much more flexible and elastic than veins and, in the arteries, blood flow is pulsatile with large pressure variations between systolic and diastolic flow. These pressure variations cause the artery walls to expand and contract. Blood flow rates in the arteries vary from about 1 to about 5 L/min. Ginsburg, U.S. Pat. No. 4,873,978, discloses an arterial filtering system, which includes a catheter with a strainer device at its distal end. This device is inserted into the vessel downstream from the treatment site and, after treatment, the strainer is collapsed around the entrapped emboli and removed from the body. The Ginsburg device could not withstand flow rates of 5 L/min. It is designed for only small arteries and therefore could not capture emboli destined for all parts of the body. Ing. Walter Hengst GmbH & Co, German Patent DE 34 17 738, also discloses another arterial filter having a folding linkage system which converts the filter from the collapsed to the expanded state.




Filters mounted to the distal end of guidewires have been proposed for intravascular blood filtration. A majority of these devices includes a filter which is attached to a guidewire and is mechanically actuated via struts or a pre-shaped basket which deploys in the vessel. These filters are typically mesh “parachutes” which are attached to the shaft of the wire at the distal end and to wire struts which extend outward in a radial direction at their proximal end. The radial struts open the proximal end of the filter to the wall of the vessel. Blood flowing through the vessel is forced through the mesh thereby capturing embolic material in the filter. These devices are self-directing and can be placed intravascularly. However, one major disadvantage associated with the current devices is that the steerability of the guidewire may be altered as compared to the conventional guidewires due to the size of the filter. The guidewire may bend, kink, and/or loop around in the vessel, making insertion of the filter through a complex vascular lesion difficult.




During endovascular procedures, it is not uncommon to exchange one endovascular device for another over the guidewire. However, the guidewire position is often lost or compromised during the exchange of devices. For example, during coronary revascularization, it is often required to exchange of one guide catheter for another guide catheter possessing different qualities, e.g., a larger diameter guide to deliver a specialized angioplasty device, a smaller diameter guide to prevent deep intubation and/or pressure damping, a different guide shape, or a guide catheter containing side holes. It is known that there are few interventional maneuvers as challenging as attempting to maintain distal guidewire access while trying to exchange one guiding catheter for another without compromising the guidewire position.




What is needed are simple and safe blood filtering and guidewire systems which can be temporarily placed in the arteries and veins to prevent distal embolization during endovascular procedures, and can be used to introduce and/or exchange various instruments to a region of interest without compromising the position of the filter or guidewire. Existing devices are inadequate for this purpose.




SUMMARY OF THE INVENTION




The present invention provides devices and methods for introduction of endovascular devices, e.g., guide catheters, atherectomy catheters, angioplasty catheters, intravascular ultrasound catheters, or stent-deployment catheters, and for protecting a patient from distal embolization during cardiovascular procedures. More specifically, a guided filter system with support wire is disclosed for capturing embolic material generated during the procedure and for directing or exchanging other devices to a region of interest in an artery or vein.




In one embodiment, the filter system comprises a guidewire and a support wire having an expandable filter, e.g., a parachute, basket, or scroll, mounted on a distal region of the support wire. The support wire is adapted for percutaneous insertion into an artery or vein and is adapted to receive an endovascular instrument. The distal region of the support wire includes a wire guide, which slideably engages the guidewire. In certain embodiments, the wire guide comprises a ring having an aperture adapted to receive the guidewire.




In another embodiment, the filter comprises an expansion frame and a mesh disposed over the frame. The filter can be placed in a collapsed condition to facilitate entry into a vessel and an enlarged condition to capture embolic material in the vessel. In certain embodiments, the frame comprises a plurality of struts bonded to the guidewire at a first end, and the struts expand radially outward at a second end. The construction and use of expansion means and associated filter mesh have been thoroughly discussed in earlier applications including Barbut et al., U.S. application Ser. No. 08/533,137, filed Nov. 7, 1995, Barbut et al., U.S. application Ser. No. 08/580,223, filed Dec. 28, 1995, Barbut et al., U.S. application Ser. No. 08/584,759, filed Jan. 9, 1996, Barbut et al., U.S. application Ser. No. 08/640,015, filed Apr. 30 1996, Barbut et al., U.S. application Ser. No. 08/645,762, filed May 14, 1996, and Barbut et al., U.S. Pat. No. 5,662,671, and the contents of each of these prior applications are expressly incorporated herein by reference.




The methods of the present invention include deployment of a percutaneous medical instrument during an endovascular procedure to remove plaque and/or thrombi from the coronary artery, aorta, common carotid artery, external and internal carotid arteries, brachiocephalic trunk, middle cerebral artery, basilar artery, subclavian artery, brachial artery, axillary artery, iliac artery, renal artery, femoral artery, popliteal artery, celiac artery, superior mesenteric artery, inferior mesenteric artery, anterior tibial artery, posterior tibial artery, and all other arteries carrying oxygenated blood. The methods also include prevention of distal embolization during an endovascular procedure to remove thrombi and/or foreign bodies in the venous circulation, including the superior vena cava, inferior vena cava, external and internal jugular veins, brachiocephalic vein, pulmonary artery, subclavian vein, brachial vein, axillary vein, iliac vein, renal vein, femoral vein, profunda femoris vein, great saphenous vein, portal vein, splenic vein, hepatic vein, and azygous vein.




In a first method of using the guided filter system, the distal end of the guidewire is inserted percutaneously through an artery or vein and advanced into or beyond a region of interest, typically a stenotic lesion caused by buildup of atherosclerotic plaque and/or thrombi. In a collapsed condition, the filter and the distal region of the support wire are advanced over the guidewire, having the wire guide of the support wire engaging the guidewire, i.e., like a monorail catheter engaging a guidewire. The filter is expanded downstream of the vascular occlusion, and the guidewire is withdrawn and removed from the body. The distal region of an endovascular device, such as an atherectomy, stent-deployment, or angioplasty catheter, is inserted over the support wire and advanced to the region of interest. After the stenotic lesion is removed or otherwise treated by the endovascular device and an adequate lumenal diameter is established, the filter is collapsed and removed, together with the captured embolic debris, from the vessel by withdrawing the support wire.




In another method, after the guidewire and the support wire with the expanded filter are positioned in a vessel distal to the region of interest, the endovascular device is inserted over both the guidewire and the support wire to position within the region of interest. During certain cardiovascular procedures, especially coronary revascularization, exchange of endovascular instruments and catheters is needed and is difficult to accomplish because the initial guidewire positioning across the region of interest is often lost as the first device is withdrawn. Using the guided filter system, the guidewire and the support wire are both advanced distal to the region of interest. If the position of the guidewire is lost during the withdrawal of the first device, the second device that needs to be exchanged can be advanced over the support wire to be positioned within the region of interest.




It will be understood that there are several advantages in using the devices and methods disclosed herein for capturing and removing embolic debris during endovascular procedures. For example, the guided filter system (1) is particularly well suited for temporary filtration of blood in any vessel to entrap embolic debris, thereby minimizing neurologic, cognitive, and cardiac complications associated with distal embolization, (2) can withstand high arterial blood flow for an extended time, (3) includes a mesh that is sufficiently porous to allow adequate blood flow in a blood vessel while capturing emboli, (4) can be used to direct an endovascular catheter to a region of interest in the vessel, (5) can be used to exchange medical instruments without compromising the position of the guidewire, and (6) can be used in adult and pediatric patients.











BRIEF DESCRIPTION OF THE DRAWINGS





FIG. 1A

depicts an embodiment of a support wire having a filter in a collapsed condition according to the present invention.





FIG. 1B

depicts the support wire of

FIG. 1A

having the filter in an expanded condition.





FIG. 1C

depicts a cross-sectional view through section line C—C of the support wire depicted in FIG.


1


B.





FIG. 1D

depicts the support wire of

FIG. 1C

having a guidewire received through the wire guide mounted within the filter.





FIG. 1E

depicts the support wire of

FIG. 1C

having a guidewire received through the wire guide mounted proximal to the filter.





FIG. 1F

depicts the support wire of

FIG. 1C

having a guidewire received through the wire guide mounted distal to the filter.





FIG. 1G

depicts the guidewire and the support wire carried within a rapid exchange catheter.





FIG. 1H

depicts the catheter of

FIG. 1G

deployed over an atheromatous lesion in a vessel.





FIG. 1I

depicts the guidewire and the support wire carried within a rapid exchange catheter.





FIG. 1J

depicts the guidewire and the support wire carried within a rapid exchange catheter.





FIG. 1K

depicts the guidewire and the support wire carried within a rapid exchange catheter.





FIG. 2A

depicts an embodiment of a distal end of the guidewire.





FIG. 2B

depicts an alternative embodiment of the distal end of the guidewire.





FIG. 2C

depicts another alternative embodiment of the distal end of the guidewire.





FIG. 3A

depicts another embodiment of the filter shaped as a parachute.





FIG. 3B

depicts another embodiment of the filter shaped as an eggbeater.





FIG. 4A

depicts a guidewire inserted across a vascular occlusion.





FIG. 4B

depicts the filter and support wire engaging the guidewire with the filter expanded beyond the vascular occlusion.





FIG. 4C

depicts an angioplasty catheter inserted over the support wire.





FIG. 4D

depicts an angioplasty catheter inserted over the guidewire and the support wire.











DETAILED DESCRIPTION




In a first embodiment, a filter system for temporary placement in a vessel, either an artery or vein, is provided as depicted in

FIGS. 1A

,


1


B,


1


C, and


1


D. The filter system includes support wire


10


having a proximal end, distal region


11


, and expandable filter


20


mounted at the distal region. The filter comprises expansion frame


22


and mesh


25


which is sonic welded or adhesive bonded to struts


28


of the expansion frame. Anticoagulants, such as heparin and heparinoids, may be applied to mesh


25


to reduce thrombi formation on the mesh. The filter can be collapsed as shown in

FIG. 1A

to facilitate insertion into a vessel, and thereafter expanded as shown in FIG.


1


B. Wire guide


26


is included in distal region


11


of the support wire. The wire guide may be mounted within the filter (as shown in FIG.


1


B and

FIG. 1C

) or at any other suitable position on support wire


10


proximal of the filter (as shown in FIG.


1


E), or on a distal extension of the support wire which extends beyond the filter (as shown in FIG.


1


F). In certain embodiments, the support wire may comprise a ring. A cross-sectional view of the support wire through section line C—C is depicted in FIG.


1


C. The design and construction of a variety of filters for use on guidewire is described in detail in Tsugita et al., U.S. Pat. No. 5,911,734, the disclosure of which is expressly incorporated herein by reference in its entirety.




In another embodiment, the filter further includes a capture sheath which covers the filter and is removeable from the filter, the sheath having a port in its distal region adapted to receive the guidewire in the manner of a rapid exchange catheter. In

FIG. 1G

, support wire


10


is inserted in lumen


51


of a rapid exchange catheter


50


. The catheter includes side port


60


in its distal region, adapted to receive guidewire


30


. In

FIG. 11

, the catheter includes skive


61


which receives guidewire


30


. In

FIG. 1J

, elongate member


70


carries tubular segment


75


having skive


77


at a distal region of elongate member


70


. The tubular segment acts as a capture sheath for the filter while the skive receives the guidewire. In

FIG. 1K

, elongate member


70


carries first and second tubular segments,


75


and


79


, adapted to receive, respectively, the filter and the guidewire.




When in use, guidewire


30


is first inserted into a vessel and advanced distal to the region of interest. The catheter, which carries the filter in lumen


51


, is inserted over the guidewire, the guidewire engaged through side port


60


. The filter is advanced distally passing atheromatous lesion


100


. The guidewire can then be withdrawn and catheter


50


drawn proximal, leaving the catheter and the filter inserted in the vessel as depicted in FIG.


1


H. Catheter


50


is then removed from the vessel. Expansion frame


22


is expanded to capture embolic materials downstream the atheromatous lesion. An endovascular device, such as an angioplasty catheter with or without a stent, can be inserted over support wire


10


to position adjacent atheroma


100


. After vascular procedures are performed with the endovascular device(s), the device(s) are withdrawn and removed from the vessel. The filter with the captured emboli is then contracted and removed.




The filter system also includes guidewire


30


having a proximal end and distal end


33


. The guidewire is slideably received by support wire


10


through wire guide


26


as depicted in FIG.


1


D. The filter system further includes endovascular devices, such as atherectomy catheters, endovascular imaging devices, stent-deployment catheters, angioplasty catheters, pressure monitors, electrophysiology catheters, and aspirators, which are adapted to receive guidewire


30


and/or support wire


10


in their lumens.




Different constructions of distal end


33


of the guidewire are depicted in

FIGS. 2A

,


2


B, and


2


C. Distal end


33


may assume a substantially linear configuration relative to the proximal end of the guidewire as depicted in FIG.


2


A. Alternatively, distal end


33


may assume an angular configuration relative to the proximal end of the guidewire as depicted in FIG.


2


A. Distal end


33


may be shaped like a fishhook as depicted in FIG.


2


C. The distal region of the guidewire may be constructed of a flexible material to facilitate entry through a region of interest, and preferably is equipped with an atraumatic tip as is known in the art. The embodiments in

FIGS. 2B and 2C

, having a curvilinear design, are particularly useful in achieving access to a complex lesion in a tortuous vessel.





FIGS. 3A and 3B

depict alternative embodiments of expandable filter


20


mounted on the distal region of support wire


10


. In

FIG. 3A

, filter


20


comprises a parachute frame, and mesh


25


which is welded (e.g., sonic or laser) or adhesive bonded to struts


28


. Wire guide


26


is included in the distal region of the support wire and projects distally from filter


20


for engaging a guidewire. In

FIG. 3B

, filter


20


comprises compressible struts


22


, and mesh


25


. In an expanded condition, filter


20


assumes the shape of an eggbeater.




By way of example, when the filter system as disclosed herein is intended for use in the aorta, the area of the mesh required for the device is calculated from Bemoulli's equation as described in our earlier applications including Barbut et al., U.S. application Ser. No., U.S. application Ser. No. 08/553,137, filed Nov. 7, 1995, Barbut et al., U.S. application Ser. No. 08/580,223, filed Dec. 28, 1995, Barbut et al., U.S. application Ser. No. 08/584,759, filed Jan. 9, 1996, Barbut et al., U.S. application Ser. No. 08/640,015, filed Apr. 30, 1996, and Barbut et al., and U.S. application Ser. No. 08/645,762, filed May 14, 1996, all of which are incorporated herein by reference.




In an embodiment of the guided filter system that is to be used in the aorta, mesh with dimensions within the following ranges is desirable: mesh area is 0.004-5 in


2


, more preferably 0.007-4 in


2


, more preferably 0.010-3 in


2


, more preferably 0.015-2 in


2


, more preferably 0.020-1 in


2


, more preferably 0.025-0.076 in


2


; mesh thickness is 60-280 μm, more preferably 70-270 μm, more preferably 80-260 μm, more preferably 90-250 μm, more preferably 100-250 μm, more preferably 120-230 μm, more preferably 140-210 μm; thread diameter is 30-145 μm, more preferably 40-135 μm, more preferably 50-125 μm, more preferably 60-115 μm, more preferably 70-105 μm, and pore size is 500 μm or less, more preferably 400 μm or less, more preferably 300 μm or less, more preferably 200 μm or less, more preferably 100 μm or less, more preferably 50 μm or less and usually larger than at least a red blood cell. In a preferred embodiment of the invention, mesh area is 2-8 in


2


, mesh thickness is 60-200 μm, thread diameter is 30-100 μm, and pore size is 50-300 μm. In a further preferred embodiment of the invention, mesh area is 3-5 in


2


, mesh thickness is 60-150 μm, thread diameter is 50-80 μm, and pore size is 100-250 μm. In other embodiments, the filter comprises a thin film laser cut with holes to allow blood flow. Typical dimensions include pore size of 20-500 μm, a thickness of 0.0005-0.003 inches, and area approximately same as for meshes described above.




In other embodiments, the filter comprises a thin film laser cut with holes to allow blood flow. Typical dimensions include pore size of 20-500 μm, a thickness of 0.0005-0.003 inches, and area approximately same as for meshes described above.




Once appropriate physical characteristics are determined, suitable mesh can be found among standard meshes known in the art. For example, polyester meshes may be used, such as meshes made by Saati Corporations and Tetko Inc. These are available in sheet form and can be easily cut and formed into a desired shape. In a preferred embodiment, the mesh is welded (e.g. sonic or laser) or sewn into a cone shape. Other meshes known in the art, which have the desired physical characteristics, are also suitable. Anticoagulants, such as heparin and heparinoids, may be applied to the mesh to reduce the chances of blood clotting on the mesh. Anticoagulants other than heparinoids also may be used, e.g., monoclonal antibodies such as ReoPro (Centocor). The anticoagulant may be painted or sprayed onto the mesh. A chemical dip comprising the anticoagulant also may be used. Other methods known in the art for applying chemicals to mesh may be used.




In use, as depicted in

FIG. 4A

, guidewire


30


is inserted percutenously through a peripheral artery or vein and advanced typically in the direction of blood flow. However, guidewire


30


may be inserted and advanced in a direction opposite the blood flow, e.g., retrograde through the descending aorta to reach the coronary artery. Distal end


33


of the guidewire is passed through occluding lesion


100


, typically an atheromatous plaque, and positioned distal to the occlusion. Support wire


10


of

FIG. 1A

is inserted over the proximal end of guidewire


30


through wire guide


26


, and advanced distally until filter


20


is positioned distal to plaque


100


as depicted in FIG.


4


B. By having wire guide


26


engage the guidewire, the filter and the support wire can be easily steered intravascularly to reach the region of interest. Filter


20


is expanded to capture embolic material, such as calcium, thrombi, plaque, and/or tissue debris. Guidewire


30


is then withdrawn, leaving support wire


10


in position to direct an endovascular device to plaque


100


.




Percutaneous translumenal angioplasty has been successful in treating arterial stenoses as well as occlusive venous thrombosis resistant to thrombolysis. See American Heart Journal, 125 (2 Pt 1): 362-6 (1993). Angioplasty catheter


40


, which has angioplasty balloon


42


mounted on the distal region, is inserted over support wire


10


as depicted in FIG.


4


C. In a deflated state, the angioplasty balloon is advanced over support wire


10


to a position adjacent plaque


100


. The atheromatous plaque is compressed by inflating balloon


42


, thereby dilating the stenosis in the vessel. In certain embodiments, the angioplasty catheter includes infusion port


44


proximal and perfusion port


45


distal to balloon


42


. Infusion port


44


may be used to administer pharmaceutical agents, e.g., t-PA, adenosine, or nitroglycerin through the catheter lumen (not shown). Oxygenated medium or blood may be infused through port


45


to maintain perfusion to distal organs during angioplasty. In certain embodiments, a stent is closely associated with the angioplasty balloon. The stent is typically crimped onto the balloon and is capable of controlled radial expansion in the region of interest upon application of a radial, outwardly extending force from the interior of the stent. The construction of the catheter system carrying a stent is described in detail in Jang et al., U.S. Pat. No. 5,749,848, which is incorporated herein by reference in its entirety.




The angioplasty catheter or other endovascular instrument is withdrawn from the vessel after completion of angioplasty. Embolic material generated during the angioplasty is captured and retained by filter


20


. The filter is then contracted, and with captured embolic material, is withdrawn from the vessel and removed from the patient's body.




Alternatively, after filter


20


is positioned and expanded distal to plaque


100


, guidewire


30


and support wire


10


may remain in the vessel across plaque


100


as depicted in FIG.


4


D. Angioplasty catheter


40


is then inserted over both guidewire


30


and support wire


10


to a position adjacent plaque


100


. If an atherectomy device, for example, is required to remove plaque remaining after angioplasty, angioplasty catheter


40


is withdrawn, with or without the guidewire, and an atherectomy catheter is inserted over guidewire


30


and/or support wire


10


to a position adjacent the plaque. In this way, if the position of guidewire


30


across the plaque is lost during the removal of angioplasty catheter


40


, support wire


10


is available to direct another endovascular device to the region of interest. This method is particularly useful for exchanging guide catheters during coronary revascularization.




The length of the guidewire and the support wire will generally be between 30 and 300 centimeters, preferably approximately between 50 and 180 centimeters. The filter will be capable of expanding to an outer diameter of at least 0.2 centimeters, more preferably at least 0.5 centimeters, more preferably at least 1.0 centimeters, more preferably at least 1.5 centimeters, more preferably at least 2.0 centimeters, more preferably at least 2.5 centimeters, more preferably at least 3.0 centimeters, more preferably at least 3.5 centimeters, more preferably at least 4.0 centimeters, more preferably at least 4.5 centimeters, more preferably at least 5.0 centimeters. These ranges cover suitable diameters for both pediatric and adult use. The foregoing ranges are set forth solely for the purpose of illustrating typical device dimensions. The actual dimensions of a device constructed according to the principles of the present invention may obviously vary outside of the listed ranges without departing from those basic principles.




Although the foregoing invention has, for the purposes of clarity and understanding, been described in some detail by way of illustration and example, it will be obvious that certain changes and modifications may be practiced which will still fall within the scope of the appended claims. Moreover, it will be understood that each and every feature described for any given embodiment or in any reference incorporated herein, can be combined with any of the other embodiments described herein.



Claims
  • 1. A percutaneous filter system, comprising:a guidewire; a support-wire having a proximal end, a distal end, a distal region, and an expandable filter mounted on the distal region of the support wire, the support wire adapted to receive a percutaneous medical instrument; and a sheath which removeably covers the distal end of the support wire and the filter, the sheath having a proximal end, a distal end, a distal region, and a lumen extending therethrough, which receives the filter and an aperture adapted to pass the guidewire, wherein, during use, the guidewire is positioned in a vessel at a region of interest, the sheath carrying the support wire is advanced along the guidewire until the filter reaches the region of interest, and the sheath is withdrawn to expose the filter.
  • 2. The percutaneous filter system of claim 1, wherein the sheath comprises a catheter and the aperture adapted to pass the guidewire comprises a skive port positioned in the distal region of the sheath.
  • 3. The percutaneous filter system of claim 1, wherein the sheath comprises a catheter and the aperture adapted to pass the guidewire comprises a cylindrical segment secured to the distal region of the sheath.
  • 4. The percutaneous filter system of claim 1, further comprising an elongate member having a distal end and a proximal end, the sheath carried at the distal end of the elongate member, the aperture adapted to pass the guidewire comprising a skive port positioned in the distal region of the sheath.
  • 5. The percutaneous filter system of claim 1, further comprising an elongate member having a distal end and a proximal end, the sheath carried at the distal end of the elongate member, the aperture adapted to pass the guidewire comprising a cylindrical segment secured to the distal region of the sheath.
  • 6. The percutaneous filter system of claim 1, wherein the aperture communicates with the lumen of the sheath.
  • 7. The percutaneous filter system of claim 1, wherein the aperture is located about 10 centimeters from the distal end of the sheath.
  • 8. A method for deploying a percutaneous medical instrument, comprising steps of:providing a guidewire, a support wire, and a sheath, the support wire having an expandable filter mounted on the distal region, the sheath covering the expandable filter; advancing the guidewire into a region of interest within a vessel; advancing the sheath and the support wire along the guidewire with the sheath engaging the guidewire; withdrawing the sheath from the expandable filter; expanding the filter downstream of the region of interest; and advancing the percutaneous medical instrument over the support wire and positioning the medical instrument within the region of interest.
  • 9. The method of claim 8, wherein the sheath engages the guidewire through an aperture in a distal region of the shealth.
  • 10. The method of claim 8, wherein the step of withdrawing the sheath from the expandable filter comprises retracting the sheath proximally.
  • 11. The method of claim 8, wherein the step of withdrawing the sheath from the expandable filter comprises advancing the sheath distally.
  • 12. The method of claim 8, further comprising the step of removing the sheath from the vessel.
Parent Case Info

This application is a continuation of U.S. patent application Ser. No. 09/366,192, filed on Aug. 3, 1999 now U.S. Pat. No. 6,142,987.

US Referenced Citations (222)
Number Name Date Kind
3472230 Fogarty Oct 1969 A
3592186 Oster Jul 1971 A
3683904 Forster Aug 1972 A
3889657 Baumgarten Jun 1975 A
3952747 Kimmell, Jr. Apr 1976 A
3996938 Clark, III Dec 1976 A
4046150 Schwartz et al. Sep 1977 A
4425908 Simon Jan 1984 A
4447227 Kotsanis May 1984 A
4580568 Gianturco Apr 1986 A
4590938 Segura et al. May 1986 A
4619246 Molgaard-Nielsen et al. Oct 1986 A
4631052 Kensey Dec 1986 A
4643184 Mobin-Uddin Feb 1987 A
4650466 Luther Mar 1987 A
4662885 DiPisa, Jr. May 1987 A
4705517 DiPisa, Jr. Nov 1987 A
4706671 Weinrib Nov 1987 A
4723549 Wholey et al. Feb 1988 A
4728319 Masch Mar 1988 A
4733665 Palmaz Mar 1988 A
4790812 Hawkins, Jr. et al. Dec 1988 A
4790813 Kensey Dec 1988 A
4794928 Kletschka Jan 1989 A
4794931 Yock Jan 1989 A
4800882 Gianturco Jan 1989 A
4807626 McGirr Feb 1989 A
4842579 Shiber Jun 1989 A
4857045 Rydell Aug 1989 A
4857046 Stevens et al. Aug 1989 A
4867157 McGurk-Burleson et al. Sep 1989 A
4873978 Ginsburg Oct 1989 A
4898575 Fischell et al. Feb 1990 A
4907336 Gianturco Mar 1990 A
4921478 Solano et al. May 1990 A
4921484 Hillstead May 1990 A
4926858 Gifford, III et al. May 1990 A
4950277 Farr Aug 1990 A
4955895 Sugiyama et al. Sep 1990 A
4957482 Shiber Sep 1990 A
4969891 Gewertz Nov 1990 A
4979951 Simpson Dec 1990 A
4986807 Farr Jan 1991 A
4998539 Delsanti Mar 1991 A
5002560 Machold et al. Mar 1991 A
RE33569 Gifford, III et al. Apr 1991 E
5007896 Shiber Apr 1991 A
5007917 Evans Apr 1991 A
5011488 Ginsburg Apr 1991 A
5019088 Farr May 1991 A
5041126 Gianturco Aug 1991 A
5053008 Bajaj Oct 1991 A
5053044 Mueller et al. Oct 1991 A
5071407 Termin et al. Dec 1991 A
5071425 Gifford, III et al. Dec 1991 A
5085662 Willard Feb 1992 A
5087265 Summers Feb 1992 A
5100423 Fearnot Mar 1992 A
5100424 Jang et al. Mar 1992 A
5100425 Fischell et al. Mar 1992 A
5102415 Guenther et al. Apr 1992 A
5104399 Lazarus Apr 1992 A
5108419 Reger et al. Apr 1992 A
5133733 Rasmussen et al. Jul 1992 A
5135531 Shiber Aug 1992 A
5152771 Sabbaghian et al. Oct 1992 A
5152777 Goldberg et al. Oct 1992 A
5160342 Reger et al. Nov 1992 A
5171233 Amplatz et al. Dec 1992 A
5190546 Jervis Mar 1993 A
5195955 Don Michael Mar 1993 A
5224953 Morgentaler Jul 1993 A
5306286 Stack et al. Apr 1994 A
5314444 Gianturco May 1994 A
5314472 Fontaine May 1994 A
5318576 Plassche, Jr. et al. Jun 1994 A
5329942 Gunther et al. Jul 1994 A
5330484 Gunther et al. Jul 1994 A
5330500 Song Jul 1994 A
5350398 Pavcnik et al. Sep 1994 A
5354310 Garnic et al. Oct 1994 A
5356423 Tihon et al. Oct 1994 A
5366464 Belknap Nov 1994 A
5366473 Winston et al. Nov 1994 A
5370657 Irie Dec 1994 A
5370683 Fontaine Dec 1994 A
5376100 Lefebvre Dec 1994 A
5383887 Nadal Jan 1995 A
5383892 Cardon et al. Jan 1995 A
5383926 Lock et al. Jan 1995 A
5387235 Chuter Feb 1995 A
5395349 Quiachon et al. Mar 1995 A
5397345 Lazerus Mar 1995 A
5405377 Cragg Apr 1995 A
5409454 Fischell et al. Apr 1995 A
5415630 Gory et al. May 1995 A
5419774 Willard et al. May 1995 A
5421832 Lefebvre Jun 1995 A
5423742 Theron Jun 1995 A
5423885 Williams Jun 1995 A
5425765 Tiefenbrun et al. Jun 1995 A
5443498 Fontaine Aug 1995 A
5449372 Schmaltz et al. Sep 1995 A
4842579 Shiber Oct 1995 A
5456667 Ham et al. Oct 1995 A
5462529 Simpson et al. Oct 1995 A
5476104 Sheahon Dec 1995 A
5484418 Quiachon et al. Jan 1996 A
5507767 Maeda et al. Apr 1996 A
5512044 Duer Apr 1996 A
5527354 Fontaine et al. Jun 1996 A
5536242 Willard et al. Jul 1996 A
5540707 Ressemann et al. Jul 1996 A
5549626 Miller et al. Aug 1996 A
5562724 Vowerk et al. Oct 1996 A
5569274 Rapacki et al. Oct 1996 A
5569275 Kotula et al. Oct 1996 A
5634897 Dance et al. Jun 1997 A
5658296 Bates et al. Aug 1997 A
5662671 Barbut et al. Sep 1997 A
5669933 Simon et al. Sep 1997 A
5695519 Summers et al. Dec 1997 A
5709704 Nott et al. Jan 1998 A
5720764 Naderlinger Feb 1998 A
5728066 Daneshvar Mar 1998 A
5746758 Nordgren et al. May 1998 A
5749848 Jang et al. May 1998 A
5769816 Barbut et al. Jun 1998 A
5779716 Cano et al. Jul 1998 A
5792157 Mische et al. Aug 1998 A
5792300 Inderbitzen et al. Aug 1998 A
5795322 Boudewijn Aug 1998 A
5797952 Klein Aug 1998 A
5800457 Gelbfish Sep 1998 A
5800525 Bachinski et al. Sep 1998 A
5810874 Lefebvre Sep 1998 A
5814064 Daniel et al. Sep 1998 A
5817102 Johnson et al. Oct 1998 A
5827324 Cassell et al. Oct 1998 A
5833644 Zadno-Azizi et al. Nov 1998 A
5833650 Imran Nov 1998 A
5846260 Maahs Dec 1998 A
5848964 Samuels Dec 1998 A
5876367 Kaganov et al. Mar 1999 A
5893867 Bagaoisan et al. Apr 1999 A
5895399 Barbut et al. Apr 1999 A
5902263 Patterson et al. May 1999 A
5906618 Larson, III May 1999 A
5908435 Samuels Jun 1999 A
5910154 Tsugita et al. Jun 1999 A
5911734 Tsugita et al. Jun 1999 A
5916193 Stevens et al. Jun 1999 A
5925016 Chornenky et al. Jul 1999 A
5925060 Forber Jul 1999 A
5925062 Purdy Jul 1999 A
5925063 Khosravi Jul 1999 A
5928203 Davey et al. Jul 1999 A
5928218 Gelbfish Jul 1999 A
5934284 Plaia et al. Aug 1999 A
5935139 Bates Aug 1999 A
5938645 Gordon Aug 1999 A
5941869 Patterson et al. Aug 1999 A
5941896 Kerr Aug 1999 A
5947995 Samuels Sep 1999 A
5951585 Cathcart et al. Sep 1999 A
5954745 Gertler et al. Sep 1999 A
5976172 Homsma et al. Nov 1999 A
5980555 Barbut et al. Nov 1999 A
5989210 Morris et al. Nov 1999 A
5989271 Bonnette et al. Nov 1999 A
5989281 Barbut et al. Nov 1999 A
5993469 McKenzie et al. Nov 1999 A
5997557 Barbut et al. Dec 1999 A
6001118 Daniel et al. Dec 1999 A
6007557 Ambrisco et al. Dec 1999 A
6010522 Barbut et al. Jan 2000 A
6013085 Howard Jan 2000 A
6027520 Tsugita et al. Feb 2000 A
6042598 Tsugita et al. Mar 2000 A
6051014 Jang Apr 2000 A
6051015 Maahs Apr 2000 A
6053932 Daniel et al. Apr 2000 A
6059814 Ladd May 2000 A
6066149 Samson et al. May 2000 A
6068645 Tu May 2000 A
6086605 Barbut et al. Jul 2000 A
6117154 Barbut et al. Sep 2000 A
6129739 Khosravi Oct 2000 A
6136016 Barbut et al. Oct 2000 A
6142987 Tsugita Nov 2000 A
6152946 Broome et al. Nov 2000 A
6165200 Tsugita et al. Dec 2000 A
6168579 Tsugita Jan 2001 B1
6171327 Daniel et al. Jan 2001 B1
6171328 Addis Jan 2001 B1
6179851 Barbut et al. Jan 2001 B1
6179859 Bates et al. Jan 2001 B1
6179861 Khosravi et al. Jan 2001 B1
6203561 Ramee et al. Mar 2001 B1
6206868 Parodi Mar 2001 B1
6214026 Lepak et al. Apr 2001 B1
6221006 Dubrul et al. Apr 2001 B1
6224620 Maahs May 2001 B1
6231544 Tsugita et al. May 2001 B1
6235044 Root et al. May 2001 B1
6235045 Barbut et al. May 2001 B1
6238412 Dubrul et al. May 2001 B1
6245087 Addis Jun 2001 B1
6245088 Lowery Jun 2001 B1
6245089 Daniel et al. Jun 2001 B1
6258115 Dubrul Jul 2001 B1
6264663 Cano Jul 2001 B1
6264672 Fisher Jul 2001 B1
6270513 Tsugita et al. Aug 2001 B1
6277138 Levinson et al. Aug 2001 B1
6277139 Levinson et al. Aug 2001 B1
6280413 Clark et al. Aug 2001 B1
6287321 Jang Sep 2001 B1
6290710 Cryer et al. Sep 2001 B1
6309399 Barbut et al. Oct 2001 B1
6319268 Ambrisco et al. Nov 2001 B1
6344049 Levinson et al. Feb 2002 B1
Foreign Referenced Citations (103)
Number Date Country
28 21 048 Jul 1980 DE
34 17 738 Nov 1985 DE
40 30 998 Oct 1990 DE
199 16 162 Oct 2000 DE
0 200 688 Nov 1986 EP
0 293 605 Dec 1988 EP
0 411 118 Feb 1991 EP
0 427 429 May 1991 EP
0 437 121 Jul 1991 EP
0 472 334 Feb 1992 EP
0 472 368 Feb 1992 EP
0 533 511 Mar 1993 EP
0 655 228 Nov 1994 EP
0 686 379 Jun 1995 EP
0 696 447 Feb 1996 EP
WO 9623441 Aug 1996 EP
0 737 450 Oct 1996 EP
0 743 046 Nov 1996 EP
0 759 287 Feb 1997 EP
0 771 549 May 1997 EP
0 852 132 Jul 1998 EP
0 934 729 Aug 1999 EP
1 127 556 Aug 2001 EP
2 580 504 Oct 1986 FR
2 643 250 Aug 1990 FR
2 666 980 Mar 1992 FR
2 694 687 Aug 1992 FR
2 768 326 Mar 1999 FR
2 020 557 Jan 1983 GB
8-187294 Jul 1996 JP
764684 Sep 1980 SU
WO 9203097 Mar 1992 WO
WO 9414389 Jul 1994 WO
WO 9424946 Nov 1994 WO
WO 9601591 Jan 1996 WO
WO 9610375 Apr 1996 WO
WO 9619941 Jul 1996 WO
WO 9633677 Oct 1996 WO
WO 9717100 May 1997 WO
WO 9727808 Aug 1997 WO
WO 9742879 Nov 1997 WO
WO 9802084 Jan 1998 WO
WO 9802112 Jan 1998 WO
WO 9833443 Aug 1998 WO
WO 9836786 Aug 1998 WO
WO 9838920 Sep 1998 WO
WO 9838929 Sep 1998 WO
WO 9839046 Sep 1998 WO
WO 9839053 Sep 1998 WO
WO 9846297 Oct 1998 WO
WO 9847447 Oct 1998 WO
WO 9849952 Nov 1998 WO
WO 9850103 Nov 1998 WO
WO 9851237 Nov 1998 WO
WO 9855175 Dec 1998 WO
WO 9909895 Mar 1999 WO
WO 9922673 May 1999 WO
WO 9923976 May 1999 WO
WO 9925252 May 1999 WO
WO 9930766 Jun 1999 WO
WO 9940964 Aug 1999 WO
WO 9942059 Aug 1999 WO
WO 9944510 Sep 1999 WO
WO 9944542 Sep 1999 WO
WO 9955236 Nov 1999 WO
WO 9958068 Nov 1999 WO
WO 0007521 Feb 2000 WO
WO 0007655 Feb 2000 WO
WO 0009054 Feb 2000 WO
WO 0016705 Mar 2000 WO
WO 0049970 Aug 2000 WO
WO 0053120 Sep 2000 WO
WO 0067664 Nov 2000 WO
WO 0067665 Nov 2000 WO
WO 0067666 Nov 2000 WO
WO 0067668 Nov 2000 WO
WO 0067669 Nov 2000 WO
WO 0105462 Jan 2001 WO
WO 0108595 Feb 2001 WO
WO 0108596 Feb 2001 WO
WO 0108742 Feb 2001 WO
WO 0108743 Feb 2001 WO
WO 0110320 Feb 2001 WO
WO 0115629 Mar 2001 WO
WO 0121077 Mar 2001 WO
WO 0121100 Mar 2001 WO
WO 0126726 Apr 2001 WO
WO 0135857 May 2001 WO
WO 0143662 Jun 2001 WO
WO 0147579 Jul 2001 WO
WO 0149208 Jul 2001 WO
WO 0149209 Jul 2001 WO
WO 0149215 Jul 2001 WO
WO 0149355 Jul 2001 WO
WO 0152768 Jul 2001 WO
WO 0158382 Aug 2001 WO
WO 0160442 Aug 2001 WO
WO 0167989 Sep 2001 WO
WO 0170326 Sep 2001 WO
WO 0172205 Oct 2001 WO
WO 0187183 Nov 2001 WO
WO 0189413 Nov 2001 WO
WO 0191824 Dec 2001 WO
Non-Patent Literature Citations (21)
Entry
Onal et al., “Primary Stenting for Complex Atherosclerotic Plaques in Aortic and Iliac Stenoses”, Cardiovasc. Intervent. Radiol, (1998) 21:386-392.
Jordan Jr. et al., “Microemboli Detected by Transcranial Doppler Monitoring . . . ”, Cardiovascular Surgery, Jan. 1999, vol. 7, No. 1, pp. 33-38.
Marache et al., “Percutaneous Transluminal Venous Angioplasty . . . ”, American Heart Journal, Feb. 1993, vol. 125, No. 2, Part 1, pp. 362-366.
Waksman et al., “Distal Embolization is Common After Directional Atherectomy . . . ”, American Heart Journal, vol. 129, No. 3, pp. 430-435.
Nakanishi, T., “Catheter Intervention to Venous System Using Expandable Metallic Stents”, Rinsho Kyobu Geka, Apr. 1994 14(2): 110-4.
“Atherosclerotic Disease of the Aortic Arch as a Risk Factor of Recurrent Ischemic Stroke,” The New England Journal of Medicine, pp. 1216-1221 (May 1996).
“Endovascular Grafts, Stents Drive Interventional Radiology Growth,” Cardiovascular Device Update, 2(3):1-12 (Mar. 1996).
“Protruding Atheromas in the Thoracic Aortic and Systemic Embolization,” pp. 423-427 American College of Physicians (1991).
“Recognition and Embolic Potential of Intraaortic Atherosclerotic Debris,” American College of Cardiology (Jan. 1991).
Cragg, Andrew et al., “A New Percutaneous Vena Cava Filger,” AJR, 141:601-604 (Sep. 1983).
Cragg, Andrew et al., “Nonsurgical Placement of Arterial Endoprosthesis: A New Technique Using Nitinol Wire,” AJR, pp. 261-263 (Apr. 1983).
Diethrich et al., “Percutaneous Techniques for Endoluminal Carotid Interventions,” J. Endovasc. Surg., 3:182-202 (1996).
Fadali, A. Moneim, “A filtering device for the prevention of particulate embolization during the course of cardiac surgery,” Surgery, 64(3):634-639 (Sep. 1968).
Haissaguerre et al., “Spontaneous Initiation of Atrial Fibrillation by Ectopic Beats Originating in the Pulmonary Veins,” The New England Journal of Medicine, 339(10):659-666 (Sep. 1988).
Lesh, “Can Catheter Ablation Cure Atrial Fibrillation?” ACC Current Journal Review, pp. 38-40 (Sep./Oct. 1997).
Marache et al., “Percutaneous Transluminal Venous Angioplasty . . . ,” American Heart Journal, 125(2Pt1):362-366 (Feb. 1993).
Mazur et al., “Directional Atherectomy with the Omnicath™: A Unique New Catheter System,” Catheterization and Cardiovascular Diagnosis, 31:17-84 (1994).
Moussa, MD, Issaam “Stents Don't Require Systemic Anticoagulation . . . But the Technique (and Results) Must be Optimal,” Journal of Invasive Cardiol., 8(E):3E-7E, (1996).
Theron et al., “New Triple Coaxial Catheter System for Carotid Angioplasty with Cerebral Protection,” American Journal of Neuroradiology, 11:869-874 (1990).
Tunick et al., “Protruding atherosclerotic plaque in the aortic archo f patients with systemic embolization: A new finding seen by transesophageal echocardiography,” American Heart Journal 120(3):658-660 (Sep. 1990).
Wholey, Mark H. et al., PTA and Stents in the Treatment of Extracranial Circulation, The Journal of Invasive Cardiology, 8(E):25E-30E (1996).
Continuations (1)
Number Date Country
Parent 09/366192 Aug 1999 US
Child 09/677119 US